Ha Tay Pharmaceutical Joint Stock Company was established in 1965 under the initial name Ha Tay Pharmaceutical Enterprise.
In 2020 – Collaboration with the Japanese company ASKA, a longstanding manufacturer of hormonal drugs with four facilities in Fukushima and four facilities meeting Japanese PIC/S-GMP standards.
In the project to construct the high-tech pharmaceutical factory HATAPHAR – ASKA, ASKA has committed to supporting Ha Tay Pharmaceutical in design, training, operation, integration, and validation.
Main areas of activity
Production and sale of pharmaceuticals, medicinal materials, cosmetics, food supplements.
Import and export of pharmaceuticals, cosmetics, medicinal foods, and medical equipments.
Trading in chemicals and testing chemicals.
Vaccines, biological products, and medical device.
Steps forward in the future
Investment of 1,350 billion VND to build the high-tech pharmaceutical manufacturing plant – Hataphar.
Estimated production of 2 billion new drug products, hormone-containing drugs, and over 700 million herbal medicine-based products annually.
Creating a competitive advantage in bidding by developing drug production to EU-GMP standard.